Discover our

Services for Media

Are you a media representative looking for content on Bayer? This section provides news, press photos and more.

News
July 04, 2022
Not intended for U.S. and UK Media – New late-breaking data from Phase III ARASENS trial presented in the Game Changer oral session at the European Association of Urology Congress 2022 (EAU22)

Darolutamide plus androgen deprivation therapy and docetaxel demonstrates consistent overall survival benefits across various patient segments in metastatic hormone-sensitive prostate cancer

June 30, 2022
Not intended for U.S. and UK Media

Kerendia™ (finerenone) approved in China for the treatment of adults with chronic kidney disease associated with type 2 diabetes

June 29, 2022
Not intended for U.S. and UK Media

Bayer opens new Research & Innovation Center in Boston-Cambridge demonstrating its commitment to precision oncology

NEWS OVERVIEW
Our Media Streams